Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 100

1.

BSA Binding, molecular docking and in vitro biological screening of some new 1, 2, 4-triazole heterocycles bearing azinane nucleus.

Iqbal J, Rehman A, Abbasi MA, Siddiqui SZ, Khalid H, Laulloo SJ, Chohan TA, Rasool S, Shah SAA.

Pak J Pharm Sci. 2020 Jan;33(1):149-160.

PMID:
32122843
2.

Synthesis, Bacterial biofilm inhibition and cytotoxicity of new N-Alkyl/aralkyl-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-nitrobenzenesulfonamides.

Abbasi MA, Zeb A, Rehman A, Siddiqui SZ, Shah SAA, Shahid M, Fatima H.

Pak J Pharm Sci. 2020 Jan;33(1):41-47.

PMID:
32122829
3.

α-Glucosidase inhibitory potential and hemolytic evaluation of newly synthesized 3,4,5-trisubstituted-1,2,4-triazole derivatives.

Nafeesa K, Aziz-Ur-Rehman -, Abbasi MA, Siddiqui SZ, Rasool S, Ali Shah SA, Ashraf M, Jahan B, Lodhi MA, Khan FA.

Pak J Pharm Sci. 2019 Nov;32(6):2651-2658.

PMID:
31969298
4.

Synthesis of new S-substituted derivatives of 5-[3-(1H-indol-3-yl)propyl]-1,3,4-oxadiazol-2-ylhydrosulfide as suitable antibacterial and anticancer agents with moderate cytotoxicity.

Nazir M, Abbasi MA, Aziz-Ur-Rehman -, Siddiqui SZ, Ali Shah SA, Shahid M, Fatima H, Iftikhar S, Zaib Saleem RS.

Pak J Pharm Sci. 2019 Nov;32(6):2585-2597.

PMID:
31969290
5.

In Silico, Cytotoxic and Antioxidant Potential of Novel Ester, 3-hydroxyoctyl -5- trans-docosenoate Isolated from Anchusa arvensis (L.) M.Bieb. Against HepG-2 Cancer Cells.

Hussain S, Ullah F, Ayaz M, Ali Shah SA, Ali Shah AU, Shah SM, Wadood A, Aman W, Ullah R, Shahat AA, Nasr FA.

Drug Des Devel Ther. 2019 Dec 10;13:4195-4205. doi: 10.2147/DDDT.S228971. eCollection 2019.

6.

Synthesis, molecular docking, dynamic simulations, kinetic mechanism, cytotoxicity evaluation of N-(substituted-phenyl)-4-{(4-[(E)-3-phenyl-2-propenyl]-1-piperazinyl} butanamides as tyrosinase and melanin inhibitors: In vitro, in vivo and in silico approaches.

Raza H, Abbasi MA, Aziz-Ur-Rehman, Siddiqui SZ, Hassan M, Abbas Q, Hong H, Shah SAA, Shahid M, Seo SY.

Bioorg Chem. 2020 Jan;94:103445. doi: 10.1016/j.bioorg.2019.103445. Epub 2019 Nov 22.

PMID:
31826809
7.

Synthesis of some new N-(alkyl/aralkyl)-N-(4-methoxyphenethyl) benzene sulfonamides as antibacterial agents against Escherichia.

Abbasi MA, Fatima Z, Rehman AU, Siddiqui SZ, Ali Shah SA, Shahid M, Fatima H.

Pak J Pharm Sci. 2019 Sep;32(5):1957-1964.

PMID:
31813858
8.

Cytotoxicity of Anchusa arvensis Against HepG-2 Cell Lines: Mechanistic and Computational Approaches.

Hussain S, Ullah F, Sadiq A, Ayaz M, Shah AA, Ali Shah SA, Shah SM, Nadhman A, Ullah F, Wadood A, El-Shazly M.

Curr Top Med Chem. 2019;19(30):2805-2813. doi: 10.2174/1568026619666191105103801.

PMID:
31702502
9.

Synthesis, in vitro alpha-glucosidase inhibitory potential of benzimidazole bearing bis-Schiff bases and their molecular docking study.

Rahim F, Zaman K, Taha M, Ullah H, Ghufran M, Wadood A, Rehman W, Uddin N, Shah SAA, Sajid M, Nawaz F, Khan KM.

Bioorg Chem. 2020 Jan;94:103394. doi: 10.1016/j.bioorg.2019.103394. Epub 2019 Oct 23.

PMID:
31699396
10.

Synthesis of new isoquinoline-base-oxadiazole derivatives as potent inhibitors of thymidine phosphorylase and molecular docking study.

Zaman K, Rahim F, Taha M, Wadood A, Shah SAA, Ahmed QU, Zakaria ZA.

Sci Rep. 2019 Nov 5;9(1):16015. doi: 10.1038/s41598-019-52100-0.

11.

New triazinoindole bearing thiazole/oxazole analogues: Synthesis, α-amylase inhibitory potential and molecular docking study.

Rahim F, Tariq S, Taha M, Ullah H, Zaman K, Uddin I, Wadood A, Khan AA, Rehman AU, Uddin N, Zafar S, Shah SAA.

Bioorg Chem. 2019 Nov;92:103284. doi: 10.1016/j.bioorg.2019.103284. Epub 2019 Sep 17.

PMID:
31546207
12.

Synthesis, molecular docking and biological potentials of new 2-(4-(2-chloroacetyl) piperazin-1-yl)-N-(2-(4-chlorophenyl)-4-oxoquinazolin-3(4H)-yl)acetamide derivatives.

Mehta S, Kumar S, Marwaha RK, Narasimhan B, Ramasamy K, Lim SM, Shah SAA, Mani V.

BMC Chem. 2019 Sep 5;13(1):113. doi: 10.1186/s13065-019-0629-0. eCollection 2019 Dec.

13.

Designing of promising medicinal scaffolds for Alzheimer's disease through enzyme inhibition, lead optimization, molecular docking and dynamic simulation approaches.

Hassan M, Abbasi MA, Aziz-Ur-Rehman, Siddiqui SZ, Shahzadi S, Raza H, Hussain G, Shah SAA, Ashraf M, Shahid M, Seo SY, Malik A.

Bioorg Chem. 2019 Oct;91:103138. doi: 10.1016/j.bioorg.2019.103138. Epub 2019 Jul 22.

PMID:
31446329
14.

In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents.

Tahlan S, Kumar S, Ramasamy K, Lim SM, Shah SAA, Mani V, Narasimhan B.

BMC Chem. 2019 Jul 11;13(1):90. doi: 10.1186/s13065-019-0608-5. eCollection 2019 Dec.

15.

Molecular docking, synthesis and biological significance of pyrimidine analogues as prospective antimicrobial and antiproliferative agents.

Kumar S, Kaushik A, Narasimhan B, Shah SAA, Lim SM, Ramasamy K, Mani V.

BMC Chem. 2019 Jul 9;13(1):85. doi: 10.1186/s13065-019-0601-z. eCollection 2019 Dec.

16.

4-(4-Bromophenyl)-thiazol-2-amine derivatives: synthesis, biological activity and molecular docking study with ADME profile.

Sharma D, Kumar S, Narasimhan B, Ramasamy K, Lim SM, Shah SAA, Mani V.

BMC Chem. 2019 Apr 23;13(1):60. doi: 10.1186/s13065-019-0575-x. eCollection 2019 Dec.

17.

Design, synthesis and biological profile of heterocyclic benzimidazole analogues as prospective antimicrobial and antiproliferative agents.

Tahlan S, Kumar S, Ramasamy K, Lim SM, Shah SAA, Mani V, Pathania R, Narasimhan B.

BMC Chem. 2019 Apr 3;13(1):50. doi: 10.1186/s13065-019-0567-x. eCollection 2019 Dec.

18.

Synthesis, molecular modelling and biological significance of N-(4-(4-bromophenyl) thiazol-2-yl)-2-chloroacetamide derivatives as prospective antimicrobial and antiproliferative agents.

Sharma D, Kumar S, Narasimhan B, Ramasamy K, Lim SM, Shah SAA, Mani V.

BMC Chem. 2019 Apr 1;13(1):46. doi: 10.1186/s13065-019-0564-0. eCollection 2019 Dec.

19.

4-(2-(1H-Benzo[d]imidazol-2-ylthio)acetamido)-N-(substituted phenyl)benzamides: design, synthesis and biological evaluation.

Tahlan S, Ramasamy K, Lim SM, Shah SAA, Mani V, Narasimhan B.

BMC Chem. 2019 Feb 2;13(1):12. doi: 10.1186/s13065-019-0533-7. eCollection 2019 Dec.

20.

Computational approaches: discovery of GTPase HRas as prospective drug target for 1,3-diazine scaffolds.

Kumar S, Sharma D, Narasimhan B, Ramasamy K, Shah SAA, Lim SM, Mani V.

BMC Chem. 2019 Jul 24;13(1):96. doi: 10.1186/s13065-019-0613-8. eCollection 2019 Dec.

Supplemental Content

Loading ...
Support Center